Home >> Products >> Synvisc

Synvisc

  Quantity   Price (USD)  
Synvisc 1 kit (3 syringes)
$360.00

 

Synvisc and Viscosupplementation
Not very long ago, osteoarthritis was considered as an inevitable appendage of aging. However, with the advent of several osteoarthritis treatments, now the condition is regarded as a dynamic and largely curable ailment. And now, with the Food and Drug Administration (FDA) of the United States approving the use of synvisc injections enclosing a substance called hyaluronan (a high molecule sugar) in 1997, osteoarthritis treatment of patients suffering from acute knee pain, which was not cured by any medication or physical therapy, has become easier. One such hyaluronan product is synvisc injections that are administered directly into the affected area through a process known as viscosupplementation over a period of three to five weeks. The benefits of taking synvisc injections include respite from acute pain, restoration of joint mobility and enhanced body movement. Normally, the benefits of viscosupplementation continue for quite a few months to a year depending on the acuteness of the ailment and the condition of the patient.
??
While physicians have been recommending the use of synvisc injections for osteoarthritis treatment for quite some time now, more recently, on February 2009, the FDA approved another hyaluronan drug called Synvisc-One (G-F 20) for osteoarthritis treatment. In fact, Synvisc-One is the solitary single-injection viscosupplement that has been approved for treating osteoarthritis knee pain in the United States. The synvisc injection therapy possesses the potential to redefine the market for viscosupplementation products by extending the benefits of this osteoarthritis treatment method to a broader set of patients and reducing the total cost and burden of multiple injections.
??
How Synvisc Works
??
Synvisc is composed up of a natural substance found in normal joint fluid. Synvisc injections have been used for osteoarthritis treatment through the viscosupplementation process since 1970\'s. The synovial fluid in the knee joints of patients suffering from osteoarthritis breaks down and fails to provide the cushioning required by the knee. Administration of synvisc injections directly into the affected area of the knee through viscosupplementation lubricates and cushions the knee joint of patients enduring osteoarthritis and mitigating the severe pain. In other words, synvisc injections increase the knee fluid, relieve pain and also improve the knee joint???s ability to absorb shocks. It may be noted here that for best result, diseased osteoarthritic synovial fluid is usually removed from the knee before the first synvisc injection is administered to the patient.
??
Treatment
??
Synvisc injections are directly administered into the affected knee over the course of three weeks, each course being injected once a week. Sinvesic viscosupplementaion is an easy process that takes just a few minutes. After the injection, a patient is able to resume his/ her routine activities, but doctor may recommend avoiding any strenuous exercise for about 24 to 48 hours following the viscosupplementation. In fact, the medication is considered to be one of the best methods for osteoarthritis treatment of the knee without undergoing a surgery. Since synvisc injections are administered directly into the knee through viscosupplementation, it helps to keep away from the aftereffects of many pills that are absorbed into the bloodstream.
??
Side Effects
??
As in the case of any other intra-articular injection, synvisc viscosupplementation is also associated with some common side effects. Administering synvisc injections are known to have led to insignificant to restrained arthralgia (pain in the joints), arthritis, pain at the injection site and joint effusion or swelling owing to the accumulation of fluid in the knee joints. However, there has been no report of any serious adverse effect of using this medication for osteoarthritis treatment.
??
Precautions
??
Osteoarthritis patients having experience of grim reaction to hyaluronan, an active element in the synvisc injections and other similar products, should not be given synvisc viscosupplementation. It is also advisable not to administer synvisc injections to patients having any infection in or around the affected knee or having knee inflammation. In addition, utmost care should be taken while treating osteoarthritis patients who are allergic to egg products, bird proteins, feathers or having venous lymphatic problems in the leg should be with synvisc injections. It is essential to drain out the excess fluid present in the joints before administering the synvisc injections. Patients are advised not to undertake any strenuous task, such as lifting weights or doing rigorous work-outs at least for 48 hours after taking the synsvisc injections.